
Specialists from the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation are studying genetic predictors of radiosensitivity and radioresistance of tumors, as well as risk factors for side effects of radiation therapy, in order to predict the effectiveness of cancer treatment and reduce the likelihood of adverse reactions in patients.
AI-generated summary
The study is being conducted by specialists from the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation together with radiation therapy specialists to study genetic factors that influence the effectiveness of cancer treatment and the risk of side effects.
Specialists from the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation are studying the influence of genetic factors on the process of treating a cancer tumor to predict the effectiveness of therapy.
Doctors at the National Medical Research Center of Radiology, together with radiation therapy specialists, are studying genetic predictors of radiosensitivity and radioresistance of tumors, as well as factors associated with the risk of side effects of radiation therapy.
The purpose of the study is to better understand in the future the effectiveness of the chosen treatment method for a particular patient and reduce the likelihood of adverse reactions.
MOSCOW, October 12 - RIA Novosti. Specialists from the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation are studying the influence of genetic factors on the process of treating a cancerous tumor in order to predict the effectiveness of therapy, Andrey Kaprin, chief oncologist of the Ministry of Health of Russia, general director of the medical institution, academician of the Russian Academy of Sciences, told RIA Novosti.
“The study of genetic factors affecting the tumor response to treatment continues,” said the oncologist.
He added that doctors at the National Medical Research Center of Radiology, together with radiation therapy specialists, are studying genetic predictors of radiosensitivity and radioresistance of tumors, as well as genetic factors that may be associated with the risk of developing side effects of radiation therapy.

A study from the Korea University College of Medicine found that in patients with type 2 diabetes, stable body rhythms were associated with better glucose control: 46.3% of glucose targets reached with a regular regimen versus 20% with an irregular regimen, especially during physical activity between 12:00 pm and 6:00 pm.

Scientists at Nagoya University in Japan found that blocking the enzyme BCAT1 reduced the formation of scar tissue in the heart after a heart attack and preserved its pumping function in mice. The effect was observed both with genetic shutdown of the gene and with the use of the ERG240 inhibitor, even with a late start of treatment. Elevated levels of BCAT1 were detected in fibrotic tissues of patients with heart failure.

The Lancet published a study highlighting nuclear weapons and the malicious use of AI as the main threats to humanity that could lead to its extinction.

In the Amur Region, the first multidisciplinary rehabilitation center will open in December after major renovations. The first patients will be about 20 veterans of the Northern Military District. 388 million rubles were allocated to repair the facility.

Lancet experts have published a list of 17 global threats to humanity. The main risks of extinction by 2100 are the use of AI to create bioweapons and a nuclear conflict that could cause global famine.

In Moscow, the transfer of production of a domestic melanoma drug containing nurulimab and prolgolimab has started at the pharmaceutical plant of the Technopolis Moscow SEZ. The release will be carried out by Biocad.